Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...

Regenerative medicine, a rapidly advancing field, can be generally defined as a therapeutic methodology for the repair, ...

The Food and Drug Administration (FDA) is not likely to continue to review and approve human drugs or medical devices if the federal government ...

LUMRYZ™ generated $50.4 million in sales in the fourth quarter, up 158% year-over-year, taking the full-year total to $169.1 million, in line ...

Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to ...

The House of Delegates overwhelmingly approved on Friday a bill to ban certain food preservatives and synthetic dyes.  The vote to pass HB 2354 was 93-5. It will head to the Senate. As it happened, ...

Whether you're looking to buy weight loss, male enhancement, or certain other products, these days you're apt to look for them online, rather than at a physical store.

FDA moves to ban phenylephrine, found in dozens of popular cold medications, after research shows it performs no better than ...

The House of Delegates overwhelmingly approved on Friday a bill to ban certain food preservatives and synthetic dyes. The vote to pass HB 2354 was 93-5. It will head to the Senate. As it happened, the ...

The European Union's medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen's Alzheimer's ...

ITF, IntraBio and Orchard are among the companies that have won FDA nods in the past year for Duchenne muscular dystrophy, ...

Receiving admilparant, an oral lysophosphatidic acid receptor 1 antagonist, for 26 weeks lowered percent-predicted FVC ...